QColors: An algorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads

2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2011

Volumn , Issue , 2011, Pages 130-136

  Huang, Austin ^a   Kantor, Rami ^a   DeLong, Allison ^a   Schreier, Leeann ^a   Istrail, Sorin ^b  

^a BROWN UNIVERSITY   (United States)

^b Brown Univerity   (United States)

Author keywords

constraint programming; graph coloring; HIV; quasispecies; virology

Indexed keywords

CONSTRAINT PROGRAMMING; GRAPH COLORINGS; HIV; QUASISPECIES; VIROLOGY;

COMPUTER PROGRAMMING; CONSTRAINT THEORY;

GRAPH THEORY;

EID: 84856002192     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBMW.2011.6112365     Document Type: Conference Paper

References (56)

1. V. A. Johnson, F. Brun-Vzinet, B. Clotet, H. F. Gnthard, D. R. Kuritzkes, D. Pillay, J. M. Schapiro, and D. D. Richman, "Update of the drug resistance mutations in HIV-1: december 2009," Clin Infect Dis, vol. 47, pp. 266-285, 2008.
2. D. E. Bennett, R. J. Camacho, D. Otelea, D. R. Kuritzkes, H. Fleury, M. Kiuchi, W. Heneine, R. Kantor, M. R. Jordan, J. M. Schapiro et al., "Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update," PLoS One, vol. 4, no. 3, 2009.
3. P. A. Chan and R. Kantor, "Transmitted drug resistance in nonsubtype b HIV-1 infection," HIV Therapy, vol. 3, no. 5, pp. 447-465, 2009. [Online]. Available: http://www.futuremedicine.com/doi/abs/10.2217/hiv.09.30
4. S. Y. Rhee, M. J. Gonzales, R. Kantor, B. J. Betts, J. Ravela, and R. W. Shafer, "Human immunodeficiency virus reverse transcriptase and protease sequence database," Nucleic acids research, vol. 31, no. 1, p. 298, 2003.
5. J. Zhou, N. Kumarasamy, R. Ditangco, A. Kamarulzaman, C. K. Lee, P. C. Li, N. I. Paton, P. Phanuphak, S. Pujari, and A. Vibhagool, "The TREAT asia HIV observational database: baseline and retrospective data," JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 2, p. 174, 2005.
6. T. de Oliveira, R. W. Shafer, and C. Seebregts, "Public database for HIV drug resistance in southern africa," Nature, vol. 464, no. 7289, pp. 673-673, 2010.
7. R. Kantor, D. A. Katzenstein, B. Efron, A. P. Carvalho, B. Wynhoven, P. Cane, J. Clarke, S. Sirivichayakul, M. A. Soares, J. Snoeck, C. Pillay, H. Rudich, R. Rodrigues, A. Holguin, K. Ariyoshi, M. B. Bouzas, P. Cahn, W. Sugiura, V. Soriano, L. F. Brigido, Z. Grossman, L. Morris, A. Vandamme, A. Tanuri, P. Phanuphak, J. N. Weber, D. Pillay, P. R. Harrigan, R. Camacho, J. M. Schapiro, and R. W. Shafer, "Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration,"PLoS Med, vol. 2, no. 4, p. e112, 2005. [Online]. Available: http://dx.doi.org/10.1371%2Fjournal.pmed.0020112
8. A. Huang, J. Hogan, S. Istrail, and R. Kantor, "Stratification by HIV-1 subtype does not eliminate systematic geographical variation," Antiviral Therapy, vol. 15 Supppl, no. 2, p. A161, 2010.
9. A. Huang, J. W. Hogan, S. Istrail, A. DeLong, D. A. Katzenstein, and R. Kantor, "First-line antiretroviral treatment effects on resistance mutation prevalence in HIV-1 subtypes," 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2011.
10. D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz, "Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection," Nature, vol. 373, no. 6510, pp. 123-126, 1995.
11. L. M. Mansky, "Forward mutation rate of human immunodeficiency virus type 1 in a t lymphoid cell line*," AIDS research and human retroviruses, vol. 12, no. 4, pp. 307-314, 1996.
12. M. Goodenow, T. Huet, W. Saurin, S. Kwok, J. Sninsky, and S. Wain-Hobson, "HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions," JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 2, no. 4, p. 344, 1989.
13. J. M. Coffin, "HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy," Science, vol. 267, no. 5197, p. 483, 1995.
14. O. G. Pybus and A. Rambaut, "Evolutionary analysis of the dynamics of viral infectious disease," Nature Reviews Genetics, vol. 10, no. 8, pp. 540-550, 2009.
15. M. C. Boerlijst, S. Bonhoeffer, and M. A. Nowak, "Viral quasi-species and recombination," Proceedings: Biological Sciences, pp. 1577-1584, 1996.
16. C. Briones, A. de Vicente, C. Molina-Pars, and E. Domingo, "Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo," Gene, vol. 384, pp. 129-138, 2006. (Pubitemid 44767961)
17. C. Briones and E. Domingo, "Minority report: hidden memory genomes in HIV-1 quasispecies and possible clinical implications," AIDS Rev, vol. 10, p. 93109, 2008.
18. A. M. N. Tsibris, B. Korber, R. Arnaout, C. Russ, C. C. Lo, T. Leitner, B. Gaschen, J. Theiler, R. Paredes, and Z. Su, "Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo," PloS one, vol. 4, no. 5, 2009.
19. S. Palmer, M. Kearney, F. Maldarelli, E. K. Halvas, C. J. Bixby, H. Bazmi, D. Rock, J. Falloon, R. T. Davey, R. L. Dewar, J. A. Metcalf, S. Hammer, J. W. Mellors, and J. M. Coffin, "Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in Treatment-Experienced patients are missed by standard genotype analysis," J. Clin. Microbiol., vol. 43, no. 1, pp. 406-413, 2005. (Pubitemid 40096331)
20. M. Wirden, I. Malet, A. Derache, A. G. Marcelin, B. Roquebert, A. Simon, M. Kirstetter, L. M. Joubert, C. Katlama, and V. Calvez, "Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution," AIDS, vol. 19, no. 6, p. 630, 2005.
21. J. Lu, S. G. Deeks, R. Hoh, G. Beatty, B. A. Kuritzkes, J. N. Martin, and D. R. Kuritzkes, "Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis," JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 1, p. 60, 2006.
22. S. Kassaye, E. Lee, R. Kantor, E. Johnston, M. Winters, L. Zijenah, P. Mateta, and D. Katzenstein, "Drug resistance in plasma and breast milk after single-dose nevirapine in subtype c HIV type 1: population and clonal sequence analysis," AIDS research and human retroviruses, vol. 23, no. 8, pp. 1055-1061, 2007. (Pubitemid 47492348)
23. C. Wang, Y. Mitsuya, B. Gharizadeh, M. Ronaghi, and R. W. Shafer, "Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance," Genome research, vol. 17, no. 8, p. 1195, 2007.
24. J. Archer, M. S. Braverman, B. E. Taillon, B. Desany, I. James, P. R. Harrigan, M. Lewis, and D. L. Robertson, "Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4-using HIV-1 with ultradeep pyrosequencing," AIDS (London, England), vol. 23, no. 10, p. 1209, 2009.
25. N. Beerenwinkel and O. Zagordi, "Ultra-deep sequencing for the analysis of viral populations," Current Opinion in Virology, vol. In Press, Corrected Proof. [Online]. Available: http://www.sciencedirect.com/science/ article/pii/S1879625711000629
26. M. Lataillade, J. Chiarella, R. Yang, S. Schnittman, V. Wirtz, J. Uy, D. Seekins, M. Krystal, M. Mancini, and D. McGrath, "Prevalence and clinical significance of HIV drug resistance mutations by Ultra-Deep sequencing in Antiretroviral-Nave subjects in the CASTLE study," PloS one, vol. 5, no. 6, p. e10952, 2010.
27. B. B. Simen, M. Braverman, I. Abbate, J. Aerssens, Y. Bidet, O. Bouchez, C. Gabriel, J. Izopet, H. Kessler, A. Radonic, K. Metzner, R. Paredes, P. Recordon-Pinson, J. Sakwa, G. Schmitz-Agheguian, and M. Daumer, "A multicentre collaborative study on HIV drug resistance testing using 454 massively parallel pyrosequencing," Antiviral Therapy, vol. 15 Supp, no. 2, p. A37, 2010.
28. S. Margeridon-Thermet, N. S. Shulman, A. Ahmed, R. Shahriar, T. Liu, C. Wang, S. P. Holmes, F. Babrzadeh, B. Gharizadeh, and B. Hanczaruk, "Ultra-deep pyrosequencing of hepatitis b virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)treated patients and NRTI-naive patients," Journal of Infectious Diseases, vol. 199, no. 9, p. 1275, 2009.
29. N. Eriksson, L. Pachter, Y. Mitsuya, S. Y. Rhee, C. Wang, B. Gharizadeh, M. Ronaghi, R. W. Shafer, and N. Beerenwinkel, "Viral population estimation using pyrosequencing," PLoS Computational Biology, vol. 4, no. 5, 2008.
30. K. Westbrooks, I. Astrovskaya, D. Campo, Y. Khudyakov, P. Berman, and A. Zelikovsky, "HCV quasispecies assembly using network flows,"in Proceedings of the 4th international conference on Bioinformatics research and applications. Springer-Verlag, 2008, pp. 159-170.
31. I. A. Astrovskaya, "Inferring genomic sequences," 2011.
32. O. Zagordi, A. Bhattacharya, N. Eriksson, and N. Beerenwinkel, "ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data," BMC bioinformatics, vol. 12, no. 1, p. 119, 2011.
33. M. Pop, S. L. Salzberg, and M. Shumway, "Genome sequence assembly: Algorithms and issues," Computer, pp. 47-54, 2002.
34. S. Istrail, G. G. Sutton, L. Florea, A. L. Halpern, C. M. Mobarry, R. Lippert, B. Walenz, H. Shatkay, I. Dew, J. R. Miller et al., "Whole-genome shotgun assembly and comparison of human genome assemblies,"Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, p. 1916, 2004.
35. R. M. Idury and M. S. Waterman, "A new algorithm for DNA sequence assembly," Journal of Computational Biology, vol. 2, no. 2, p. 291306, 1995.
36. A. Sundquist, M. Ronaghi, H. Tang, P. Pevzner, and S. Batzoglou, "Whole-genome sequencing and assembly with high-throughput, short-read technologies," PLoS One, vol. 2, no. 5, p. e484, 2007.
37. D. R. Zerbino and E. Birney, "Velvet: algorithms for de novo short read assembly using de bruijn graphs," Genome research, vol. 18, no. 5, p. 821, 2008.
38. P. A. Pevzner, H. Tang, and M. S. Waterman, "An eulerian path approach to DNA fragment assembly," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 17, p. 9748, 2001.
39. M. J. Chaisson and P. A. Pevzner, "Short read fragment assembly of bacterial genomes," Genome Research, vol. 18, no. 2, p. 324, 2008.
40. J. Laserson, V. Jojic, and D. Koller, "Genovo: De novo assembly for metagenomes," in Research In Computational Molecular Biology. Springer, 2010, pp. 341-356.
41. R. Lippert, R. Schwartz, G. Lancia, and S. Istrail, "Algorithmic strategies for the single nucleotide polymorphism haplotype assembly problem,"Briefings in bioinformatics, vol. 3, no. 1, p. 23, 2002.
42. B. V. Halldrsson, D. Aguiar, and S. Istrail, "Haplotype phasing by Multi-Assembly of shared haplotypes: Phase-Dependent interactions between rare variants," in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2011, p. 88.
43. S. M. Willerth, H. A. M. Pedro, L. Pachter, L. M. Humeau, A. P. Arkin, D. V. Schaffer, and J. P. Vartanian, "Development of a low bias method for characterizing viral populations using next generation sequencing technology," PloS one, vol. 5, no. 10, pp. 255-264, 2010.
44. O. Zagordi, R. Klein, M. Daumer, and N. Beerenwinkel, "Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies," Nucleic Acids Research, 2010.
45. K. Nakamura, T. Oshima, T. Morimoto, S. Ikeda, H. Yoshikawa, Y. Shiwa, S. Ishikawa, M. C. Linak, A. Hirai, and H. Takahashi, "Sequence-specific error profile of illumina sequencers," Nucleic Acids Research, 2011.
46. C. Jabara, C. Jones, J. Anderson, and R. Swanstrom, "Accurate sampling and deep sequencing HIV-1 protease using primer ID," 2011.
47. A. Ritz, A. Bashir, and B. J. Raphael, "Structural variation analysis with strobe reads," Bioinformatics, vol. 26, no. 10, p. 1291, 2010.
48. C. Schulte, M. Lagerkvist, and G. Tack, "Gecode," Software download and online material at the website: http://www. gecode. org.
49. B. Korber, B. T. Foley, C. L. Kuiken, S. K. Pillai, and J. G. Sodroski, "Numbering positions in HIV relative to HXB2CG," Human retroviruses and AIDS, vol. 3, pp. 102-111, 1998.
50. M. R. Garey and D. S. Johnson, Computers and Intractability: A Guide to the Theory of NP-completeness. WH Freeman & Co., 1979.
51. T. R. Jensen, Graph coloring problems. John Wiley & Sons, 1994.
52. C. Bron and J. Kerbosch, "Algorithm 457: finding all cliques of an undirected graph," Communications of the ACM, vol. 16, no. 9, pp. 575-577, 1973.
53. C. Schulte, "Programming constraint inference engines," Principles and Practice of Constraint Programming-CP97, pp. 519-533, 1997.
54. L. T. Bacheler, E. D. Anton, P. Kudish, D. Baker, J. Bunville, K. Krakowski, L. Bolling, M. Aujay, X. V. Wang, and D. Ellis, "Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy," Antimicrobial agents and chemotherapy, vol. 44, no. 9, p. 2475, 2000.
55. B. T. Korber, C. Brander, B. F. Haynes, R. Koup, J. P. Moore, B. D. Walker, and D. I. Watkins, HIV Molecular Immunology Compendium 2006/2007. Los Alamos National Laboratory, 2007.
56. O. Zagordi, L. Geyrhofer, V. Roth, and N. Beerenwinkel, "Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction," Journal of Computational Biology, vol. 17, no. 3, pp. 417-428, 2010.